Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Meds & Pill Reminder MyTherapy

Meds & Pill Reminder MyTherapy

By MyTherapy

MyTherapy is a medication and health-tracking app for patients managing chronic conditions, available on iOS and Android.

The App DNA

What makes this app unique?

It removes the cognitive load of managing complex medication schedules by providing reliable reminders and clinical-grade data export for doctor visits.

For Patients managing chronic conditions or complex medication regimens who require consistent tracking and reporting tools for their healthcare providers.

What does it look like?

Key features

Medication & Refill Remindersstandard

Configurable push notifications for medication intake and prescription refill alerts.

Doctor Data Exportedge

Generates health reports and medication plans via a one-time access code for healthcare providers.

Injection Site Trackingedge

Visual log for rotating injection sites to prevent tissue damage.

How much does it cost?

freemiumFree version with ad support

The app maintains a free-to-use model by leveraging pharmaceutical and healthcare institute partnerships for revenue instead of direct user subscription fees.

Velocity

Maintenance developmentperformanceopaqueShow more...

The app maintains a maintenance-level release cadence, shipping only minor stability and performance updates. With 2 distinct versions identified in the recent window and a last update 5 days ago, the development focus remains strictly on technical reliability. There is no evidence of new feature development or live operations in the recent release history. The publisher consistently utilizes opaque release notes, providing no insight into specific functional changes.

See all version history

Who built it?

MyTherapy

1 app tracked · Medical

Explore the full publisher profile

User Sentiment

What do users think recently?

Recent user voice shows a mixed sentiment. Users appreciate reliable medication and refill reminders provide essential support for users managing complex daily health routines and monthly health reports offer valuable insights into treatment trends and symptom management for patients and doctors, but report data loss and account synchronization failures following the latest update disrupt long-term medication tracking history.

How are ratings & reviews evolving?

May 18: 2 reviews (2 positive · 0 neutral · 0 negative)May 25: 1 reviews (1 positive · 0 neutral · 0 negative)Jun 1: 2 reviews (1 positive · 0 neutral · 1 negative)Jun 8: 1 reviews (1 positive · 0 neutral · 0 negative)Jun 15: 2 reviews (0 positive · 1 neutral · 1 negative)Jun 22: 1 reviews (0 positive · 0 neutral · 1 negative)Jun 29: 2 reviews (1 positive · 0 neutral · 1 negative)Jul 6: 2 reviews (0 positive · 0 neutral · 2 negative)Jul 20: 18 reviews (11 positive · 2 neutral · 5 negative)Jul 27: 27 reviews (21 positive · 3 neutral · 3 negative)27Aug 3: 7 reviews (3 positive · 0 neutral · 4 negative)May 18Aug 3
Positive Neutral Negative
2.6

Weekly average review rating

Google Play
4.53 · 237k
App Store
4.78 · 8k

What users say, by theme

What Users Love
  • Reliable medication and refill reminders provide essential support for users managing complex daily health routines
  • Monthly health reports offer valuable insights into treatment trends and symptom management for patients and doctors
  • Intuitive interface design makes managing multiple medications and health tasks accessible for diverse user groups
What Frustrates Users
  • Data loss and account synchronization failures following the latest update disrupt long-term medication tracking history
+ 2 more themes
What Users Want 2 requests inside

70 of 99 recent reviews analyzed · high confidence · Mixed overall

Read the full review analysis

Unlock 2 more frustration themes and 2 user requests, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for Meds & Pill Reminder MyTherapy

How's the Medical market?

MyTherapy maintains a 4.5-star rating across 245,293 total ratings, positioning it as a category leader in medical adherence tools. The current maintenance-only release cadence signals a focus on stability over new market acquisition.

The rivals identified

The Analyst's Read

Key takeaways for Meds & Pill Reminder MyTherapy

Where is it heading?

The medical adherence market is consolidating around apps that offer seamless hardware integration and high-reliability notifications. MyTherapy's current maintenance-only cadence leaves it exposed to churn, as users prioritize consistent alarm performance over the app's existing clinical data export capabilities.

  • Reliability issues following the latest update (data loss, alarm failures) create a churn risk that threatens the app's long-term retention.
  • Maintenance-mode updates without feature expansion leave MyTherapy vulnerable to rivals that offer better wearable integration and hardware connectivity.

The SWOT

Core Strengths
  • Doctor-verified data export tools create a high switching cost for patients.
  • Injection site tracking provides a specialized, defensible barrier against generic pill-reminder utilities.
Critical Frictions 3 weaknesses inside
Growth Levers
  • Native wearable integration would improve reminder visibility, addressing the top user request.
Market Threats 1 threat identified

Next best moves

1 Invest · 1 Pivot · 1 Maintain

Audit notification logic because alarm failures are the top-reported reliability complaint → restore user trust and retention.

+ 2 more prioritized moves

The counter-intuitive read

The app's reliance on pharmaceutical partnerships is a retention lever…

Read the full take

Since the last report: MyTherapy remains in a maintenance-only release cycle, with no functional updates or feature additions. The primary shift is a hardening of the competitive outlook, as the persistent technical instability is now explicitly framed as a liability risk.

Bottom line

MyTherapy rests on its utility for clinical data export, but the recent data-loss incidents threaten the trust required for a medical tool. Addressing these stability regressions is the only way to protect the core user base from migrating to more reliable competitors.

Unlock 3 critical frictions, 1 market threat, 2 more prioritized moves and the analyst’s take.

Access the full report for free

Sources

  1. [1] Play Store listing, source

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Meds & Pill Reminder MyTherapy, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

MyTherapy remains in a maintenance-only release cycle, with no functional updates or feature additions. The primary shift is a hardening of the competitive outlook, as the persistent technical instability is now explicitly framed as a liability risk.

added

Liability risk identification

shifted

Partnership model framing

added

Wearable integration status

Cite this report

Marlvel.ai. “Meds & Pill Reminder MyTherapy Intelligence Report.” Updated Aug 5, 2026. https://marlvel.ai/apps/meds-pill-reminder-mytherapy

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0